Zhao S - Search Results

1

miR‑95 promotes osteosarcoma growth by targeting SCNN1A.

Geng Y, Zhao S, Jia Y, Xia G, Li H, Fang Z, Zhang Q, Tian R. Geng Y, et al. Among authors: zhao s. Oncol Rep. 2020 May;43(5):1429-1436. doi: 10.3892/or.2020.7514. Epub 2020 Feb 24. Oncol Rep. 2020. PMID: 32323794 Free PMC article.

2

Deciphering the performance of polo-like kinase 1 in triple-negative breast cancer progression according to the centromere protein U-phosphorylation pathway.

Zhao S, Geng Y, Cao L, Yang Q, Pan T, Zhou D, Liu J, Shi Z, Zhang J. Zhao S, et al. Am J Cancer Res. 2021 May 15;11(5):2142-2158. eCollection 2021. Am J Cancer Res. 2021. PMID: 34094674 Free PMC article.

3

Exosomal miR-451a Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting LPIN1.

Zhao S, Li J, Zhang G, Wang Q, Wu C, Zhang Q, Wang H, Sun P, Xiang R, Yang S. Zhao S, et al. Cell Physiol Biochem. 2019;53(1):19-35. doi: 10.33594/000000118. Cell Physiol Biochem. 2019. PMID: 31162914 Free article.

4

Exosomal MiR-1290 Promotes Angiogenesis of Hepatocellular Carcinoma via Targeting SMEK1.

Wang Q, Wang G, Niu L, Zhao S, Li J, Zhang Z, Jiang H, Zhang Q, Wang H, Sun P, Xiang R, Chang A, Yang S. Wang Q, et al. Among authors: zhao s. J Oncol. 2021 Jan 29;2021:6617700. doi: 10.1155/2021/6617700. eCollection 2021. J Oncol. 2021. PMID: 33564307 Free PMC article.

5

GPRC5A Is a Negative Regulator of the Pro-Survival PI3K/Akt Signaling Pathway in Triple-Negative Breast Cancer.

Yang L, Zhao S, Zhu T, Zhang J. Yang L, et al. Among authors: zhao s. Front Oncol. 2021 Feb 16;10:624493. doi: 10.3389/fonc.2020.624493. eCollection 2020. Front Oncol. 2021. PMID: 33680947 Free PMC article.

6

Chidamide Combined With Doxorubicin Induced p53-Driven Cell Cycle Arrest and Cell Apoptosis Reverse Multidrug Resistance of Breast Cancer.

Cao L, Zhao S, Yang Q, Shi Z, Liu J, Pan T, Zhou D, Zhang J. Cao L, et al. Among authors: zhao s. Front Oncol. 2021 Mar 2;11:614458. doi: 10.3389/fonc.2021.614458. eCollection 2021. Front Oncol. 2021. PMID: 33738256 Free PMC article.

7

Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.

Yang Q, Zhao S, Shi Z, Cao L, Liu J, Pan T, Zhou D, Zhang J. Yang Q, et al. Among authors: zhao s. J Exp Clin Cancer Res. 2021 Apr 6;40(1):120. doi: 10.1186/s13046-021-01901-1. J Exp Clin Cancer Res. 2021. PMID: 33823894 Free PMC article.

8

Over-Expression of Centromere Protein U Participates in the Malignant Neoplastic Progression of Breast Cancer.

Hao X, Qiu Y, Cao L, Yang X, Zhou D, Liu J, Shi Z, Zhao S, Zhang J. Hao X, et al. Among authors: zhao s. Front Oncol. 2021 Mar 23;11:615427. doi: 10.3389/fonc.2021.615427. eCollection 2021. Front Oncol. 2021. PMID: 33833984 Free PMC article.

9

HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer.

He Y, Ma Y, Zhu Y, Zhang J, Zhao S, Zhang D, Xu D, Li Y, Tong Z, Zhao W. He Y, et al. Among authors: zhao w, zhao s. Int J Oncol. 2024 Mar;64(3):25. doi: 10.3892/ijo.2024.5613. Epub 2024 Jan 12. Int J Oncol. 2024. PMID: 38214343 Free PMC article.

10

Functional evaluation of various ICAM3 transcript variants in diffuse large B-Cell lymphoma.

Li L, Yang C, Aruna, Zhou Q, Jiang X, Du W, Liu C, Lv P, Wang X, Fan G, Zhao S, Zhang X, Jin A, Shen W. Li L, et al. Among authors: zhao s. Leuk Lymphoma. 2022 Dec;63(12):2869-2878. doi: 10.1080/10428194.2022.2092861. Epub 2022 Jul 18. Leuk Lymphoma. 2022. PMID: 35849332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,997 results

Search Page

Filters